|
|
Volumn 379, Issue 9817, 2012, Pages 686-
|
|
Approval of biosimilars in the USA - Dead ringers?
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG;
ERYTHROPOIETIN;
BIOENGINEERING;
BIOTECHNOLOGY;
EDITORIAL;
GENETIC ENGINEERING;
HEALTH CARE COST;
IMMUNOGENICITY;
PRIORITY JOURNAL;
SAFETY;
UNITED STATES;
|
|
EID: 84857516173
PISSN: 01406736
EISSN: 1474547X
Source Type: Journal
DOI: 10.1016/S0140-6736(12)60290-6 Document Type: Editorial |
|
Times cited : (8)
|
|
References (0)
|